SkinVision

About

SkinVision is a pioneering mobile health company dedicated to the early detection of skin cancer. Founded in 2011 and headquartered in Amsterdam, the company's mission is to save 250,000 lives over the next decade by empowering individuals to take proactive control of their skin health. The core of SkinVision's service is a mobile application that utilizes a clinically validated, AI-powered algorithm to analyze photos of moles and other skin spots. This technology assesses the risk of common skin cancers, including melanoma, with a high degree of accuracy, providing users with an instant risk indication and guidance on appropriate next steps, such as visiting a healthcare professional. The application combines its advanced artificial intelligence with the expertise of dermatologists and image recognition specialists to ensure the quality and reliability of its assessments. The technology was developed based on a PhD study applying fractal geometry to medical imaging and has been validated in clinical studies with institutions like the Ludwig Maximilian University in Germany. Trusted by over two million users globally, SkinVision has facilitated more than five million skin checks and has helped identify over 50,000 cases of skin cancer. The service is offered directly to consumers and through partnerships with leading health insurance companies, healthcare providers, and employers, integrating into the existing healthcare ecosystem to make early detection more accessible, efficient, and effective. By bridging the gap between self-assessment and professional medical advice, SkinVision plays a crucial role in reducing delayed diagnoses and improving patient outcomes in the fight against skin cancer.